360 MADISON AVENUE, NEW YORK, NY
Annual Meeting Results; Stockholders Elect Directors at Lucid Diagnostics
Provides Business Update and Reports First Quarter 2026 Financial Results
Annual Report to Security Holders
Announces Closing of $18 Million Underwritten Offering of Common Stock
Announces $18 Million Underwritten Offering of Common Stock
Earnings Release
Provides Business Update and Reports Third Quarter 2025 Financial Results
Diagnostics Appoints Healthcare Industry Veteran John R. Palumbo to Board of Directors
Q1
FY 2025
Q3
Q2
FY 2024
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Amended Registration Statement for Securities Offered under a Shelf Registration
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
PRE 14A
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Amended Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
Submission Upload
Correspondence